CUSIP: 88165U109
Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,154,314
-
Share change
-
-1,737,680
-
Total reported value
-
$13,761,000
-
Price per share
-
$6.38
-
Number of holders
-
32
-
Value change
-
-$15,381,757
-
Number of buys
-
19
-
Number of sells
-
18
Quarterly Holders Quick Answers
What is CUSIP 88165U109?
CUSIP 88165U109 identifies TLOG - TETRALOGIC PHARMACEUTICALS C - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2014
-
Previous quarter:
Q4 2013
Recent filing periods for CUSIP 88165U109:
Institutional Holders of TETRALOGIC PHARMACEUTICALS C - COM (TLOG) as of Q1 2014
As of 31 Mar 2014,
TETRALOGIC PHARMACEUTICALS C - COM (TLOG) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,154,314 shares.
The largest 10 holders included
KINGDON CAPITAL MANAGEMENT, L.L.C., SPHERA FUNDS MANAGEMENT LTD., First Washington CORP, Nicholas Investment Partners, LP, EMERALD ADVISERS INC/PA, Pine River Capital Management L.P., WELLINGTON MANAGEMENT CO LLP, First Eagle Investment Management, LLC, BlackRock Fund Advisors, and Alyeska Investment Group, L.P..
This page lists
32
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.